Latest Security News

Chimeric Therapeutics has secured FDA Fast Track designation for its CHM CDH17 CAR-T therapy targeting gastroenteropancreatic neuroendocrine tumours, accelerating its path toward regulatory approval and patient access.

Ovanti Limited is set to raise approximately $1 million through a two-tranche share placement to support its US buy now, pay later expansion and ongoing legal matters.

Andromeda Metals has achieved a key financing milestone with Merricks Capital's credit approval of a A$75 million debt facility, advancing the Great White Project towards final investment decision.

Tivan Limited has fully redeemed its convertible notes issued to SBC Global Investment Fund ahead of schedule, marking a significant step in its financial restructuring. The company now plans to remove SBC’s security interests on its assets before the fiscal year ends.

Challenger Gold Limited has voluntarily suspended its ASX trading pending a significant capital raising announcement, signaling potential strategic moves ahead.

Elsight has landed a significant US$5.08 million contract with a European defence OEM, pushing its total 2025 orders from this customer to nearly US$14.7 million and signaling strong growth in unmanned systems connectivity.

CZR Resources has secured Foreign Investment Review Board approval for the sale of its Robe Mesa Iron Ore Project, marking a significant step toward closing the A$75 million transaction.

New Frontier Minerals has secured $1.59 million in funding to launch its inaugural drilling campaign targeting heavy rare earth elements, niobium, and uranium at the Harts Range Project, aligning with favorable US policies on supply chain diversification and nuclear energy.

Adelong Gold Limited has secured $455,000 from selling a non-core property to fund exploration at its Victorian gold projects, while gold processing has commenced at its Challenger Gold Mine, signaling imminent production.

Inca Minerals is poised to launch its maiden drilling campaign at the Hurricane Project in Queensland, following promising surface gold assays that reveal a broader mineralised footprint than previously known.

Mayne Pharma rebuffs Cosette's claim of a material adverse change in their merger scheme and secures FDA clearance on regulatory concerns, maintaining its commitment to the deal's completion.

Zeta Resources has received Foreign Investment Review Board approval to increase its stake in Future Metals and has fully underwritten the company’s A$2.64 million entitlement offer, ensuring the capital raise is secured.